Alto Neuroscience, Inc.
ANRO
$24.63
$0.100.41%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 20.75M | 21.88M | 23.28M | 22.88M | 21.61M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 66.36M | 66.31M | 70.24M | 69.90M | 68.61M |
| Operating Income | -66.36M | -66.31M | -70.24M | -69.90M | -68.61M |
| Income Before Tax | -63.24M | -62.26M | -64.86M | -63.18M | -61.43M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -63.24 | -62.26 | -64.86 | -63.18 | -61.43 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -63.24M | -62.26M | -64.86M | -63.18M | -61.43M |
| EBIT | -66.36M | -66.31M | -70.24M | -69.90M | -68.61M |
| EBITDA | -65.70M | -65.63M | -69.61M | -69.32M | -68.11M |
| EPS Basic | -2.21 | -2.31 | -2.41 | -2.35 | -2.55 |
| Normalized Basic EPS | -1.37 | -1.43 | -1.49 | -1.45 | -1.59 |
| EPS Diluted | -2.21 | -2.31 | -2.41 | -2.35 | -2.55 |
| Normalized Diluted EPS | -1.37 | -1.43 | -1.49 | -1.45 | -1.59 |
| Average Basic Shares Outstanding | 115.41M | 108.00M | 107.85M | 107.70M | 98.25M |
| Average Diluted Shares Outstanding | 115.41M | 108.00M | 107.85M | 107.70M | 98.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |